Long-form pieces on how market entry decisions are changing, and what that means for sequencing.
Under most-favored-nation and reference pricing, the order of entry has become a pricing decision.
Peer review assumed a human made the analytic decisions and could reconstruct them. That assumption no longer holds.
Tax and customs is the sixth dimension of market entry, and the one almost no assessment measures.
External reference pricing is a sequencing constraint, not a fact of life.
The approval you already hold determines which markets open next.